Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01149096 · ClinicalTrials.gov registry record · Phase 3
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT01149096 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 13 participants.
The verdict
NCT01149096, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
This randomized clinical trial is studying the side effects of collection of bone marrow from donors treated with or without filgrastim. Giving colony-stimulating factors, such as filgrastim (G-CSF), to donors helps the stem cells move from the bone marrow to the blood so they can be collected and stored.
Interventions
- OTHER Laboratory Biomarker Analysis
- BIOLOGICAL Filgrastim
- PROCEDURE Bone Marrow Donation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-06-14 |
| Est. Completion | 2016-09-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01149096
The ClinicalTrials.gov registry entry for NCT01149096 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01149096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01149096 about?
NCT01149096 is a clinical study titled "Collection of Bone Marrow From Donors Treated With or Without Filgrastim". This randomized clinical trial is studying the side effects of collection of bone marrow from donors treated with or without filgrastim. Giving colony-stimulating factors, such as filgrastim (G-CSF), to donors helps the stem cells move from the bone marrow to the blood so they can be collected and s...
What is the current status of trial NCT01149096?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2010-06-14. Estimated completion is 2016-09-30.
What interventions are being tested in trial NCT01149096?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Filgrastim (BIOLOGICAL), Bone Marrow Donation (PROCEDURE).
Who is sponsoring clinical trial NCT01149096?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.